Summary
The discussion centers on the advancements in colorectal cancer screening, particularly through the introduction of the SHIELD blood test developed by Garden Health. Dr. Amir Ali Talizaz, co-founder and co-CEO of Garden Health, highlights the significant gap in colorectal cancer screening, with approximately one in three eligible Americans remaining unscreened. He emphasizes that while traditional screening methods like colonoscopy have been available for years, barriers such as patient discomfort and logistical challenges have hindered participation.
The SHIELD blood test represents a breakthrough in cancer screening, being the first FDA-approved blood test for colorectal cancer that is covered by Medicare and other major insurers. Dr. Talizaz notes that the test has shown a high adherence rate among patients, with over 90% completing the screening when ordered by their physicians. This innovative approach aims to engage patients who have previously avoided screening, potentially leading to earlier detection and treatment of colorectal cancer.
Looking ahead, Dr. Talizaz expresses optimism about the future of colorectal cancer screening, advocating for strong partnerships between Garden Health and health systems to enhance patient outreach and care pathways. He envisions a comprehensive screening strategy that not only increases participation rates but also significantly reduces colorectal cancer mortality, particularly among younger populations. The conversation underscores the importance of integrating new technologies into existing healthcare frameworks to improve patient outcomes and accessibility.
Show Notes
In this episode, Dr. AmirAli Talasaz, Co-Founder and Co-CEO of Guardant Health, discusses how blood-based screening can help close persistent colorectal cancer screening gaps and reach millions of unscreened patients. He also explores how the Shield Blood Test can increase screening participation, reconnect unscreened patients with health systems and enable earlier detection of colorectal cancer, particularly in rural and underserved communities.
This episode is sponsored by Guardant Health.
More from Becker’s Healthcare Podcast
This episode recorded live at the Becker's 11th Annual Health IT + Digital Health + RCM Conference features Chris Carmody, Chief Technology Officer, UPMC, who discusses using AI to turn growing volumes of healthcare data into actionable clinical insights, reduce fragmentation and create a more seamless experience across care settings.
In this episode, Dr. Patricia Henwood, EVP, Chief Clinical Officer at Jefferson Health, discusses the health system’s approach to AI integration, including its intent, integration, and impact framework, ambient AI results, and patient facing AI voice agents designed to improve care access, clinician efficiency, and patient experience.
Andy Colbert, Senior Managing Director at Ziegler, discusses the forces shaping ASC ownership and transactions in 2027, including joint ventures, private equity investment, and physician alignment. He also covers deal structure, succession planning, rising operating costs, and developing the next generation of physician leaders.
In this episode, Jody Reyes, Chief Operating Officer of the Clinical Enterprise at UI Health Care, University of Iowa Health Care, joins the podcast to discuss the importance of accountability and ownership in healthcare leadership. She also shares insights on navigating the changing economics of healthcare and adapting operational strategies to meet evolving organizational challenges.
This episode recorded live at the Becker's 11th Annual Health IT + Digital Health + RCM Conference features Deb Anderson, MBA, Chief Information Officer, Endeavor Health, discussing the integration of three electronic health records into one system, technology simplification, and strategies for managing costs while advancing digital transformation.